1. Zha J, He J, Wu C, Zhang M, Liu X, Zhang J*. Designing drugs and chemical probes with the dualsteric approach. Chem Soc Rev. 2023, 52: 8651-8677.   [HTML][PDF]

2. Zhong J, Guo Y, Lu S, Song K, Wang Y, Feng L, Zheng Z, Zhang Q, Wei J, Sang P, Shi Y, Cai J, Chen G, Liu C*, Yang X*, Zhang J*. Rational design of a sensitivity-enhanced tracer for discovering efficient APC–Asef inhibitors. Nat Commun. 2022, 13(1): 4961.   [HTML][PDF]

3. Lu S*, He X, Yang Z, Chai Z, Zhou S, Wang J, Rehman AU, Ni D, Pu J, Sun J*, Zhang J*. Activation pathway of a G protein-coupled receptor uncovers conformational intermediates as novel targets for allosteric drug design. Nat Commun. 2021, 12(1): 4721.   [HTML][PDF]
(ESI Top1% highly cited paper)

4. Ni D, Wei J, He X, Rehman AU, Li X, Qiu Y, Pu J, Lu S*, Zhang J*. Discovery of cryptic allosteric sites using reversed allosteric communication by a combined computational and experimental strategy. Chem Sci. 2021, 12: 464 - 476.   [HTML][PDF]
(Editor’s Choice & ESI Top1% highly cited paper)

5. Ni D, Li Y, Qiu Y, Lu S*, Zhang J*. Combining allosteric with orthosteric drugs to overcome drug-resistance. Trends Pharmacol Sci. 2020, 41(4): 336-348.   [HTML][PDF]

6. Lu S, Shen Q, Zhang J*. Allosteric methods and their Applications: Facilitating the Discovery of Allosteric Drugs and the Investigation of Allosteric Mechanisms. Acc Chem Res. 2019, 52(2): 492-500.   [HTML][PDF]
(ESI Top1% highly cited paper)

7. Lu S, He X, Ni D, Zhang J*. Allosteric modulator discovery: from serendipity to structure-based design. J Med Chem. 2019, 62(14): 6405-6421.   [HTML][PDF]
(ESI Top1% highly cited paper, and was recommended by Faculty 1000 for 4 times.)

8. Lu S*, Ni D, Wang C, He X, Lin H, Wang Z*, Zhang J*. Deactivation pathway of Ras GTPase underlies conformational substates as targets for drug design. ACS Catalysis. 2019, 9(8): 7188-7196.   [HTML][PDF]

9. Lu S, Zhang J*. Small Molecule Allosteric Modulators of G-Protein-Coupled Receptors: Drug-Target Interactions. J Med Chem. 2019, 62(1): 24-45.   [HTML][PDF]
(ESI Top1% highly cited paper)

10. Huang Z, Zhao J, Deng W, Chen Y, Shang J, Song K, Zhang L, Wang C, Lu S, Yang X, He B, Min J, Hu H, Tan M, Xu J, Zhang Q, Zhong J, Sun X, Mao Z, Lin H, Xiao M, Chin YE, Jiang H, Xu Y*, Chen G*, Zhang J*. Identification of a cellularly active SIRT6 allosteric activator. Nat Chem Biol. 2018, 14(12): 1118-1126.   [HTML][PDF]
(This paper was recommended by BioCentury )

11. Yang X, Zhong J, Zhang Q, Qian J, Song K, Ruan C, Xu J, Ding K, Zhang J*. Rational Design and Structure Validation of a Novel peptide Inhibitor of the Adenomatous Polyposis Coli (APC)-Rho Guanine Nucleotide Exchange Factor 4 (Asef) Interaction. J Med Chem. 2018, 61(17): 8017-8028.   [HTML][PDF]

12. Jiang H, Deng R, Yang X, Shang J, Lu S, Zhao Y, Song K, Liu X, Zhang Q, Chen Y, Chinn YE, Wu G, Li J, Chen G, Yu J*, Zhang J*. Peptidomimetic inhibitors of APC-Asef interaction block colorectal cancer migration. Nat Chem Biol. 2017, 13: 994 - 1001.   [HTML][PDF]
(Recommended by "Research Watch" in , 2017)

13. Shen Q, Cheng F, Song H, Lu W, Zhao J, An X, Liu M, Chen G, Zhao Z*, Zhang J*. Proteome-scale investigation of protein allosteric regulation perturbed by somatic mutations in 7,000 cancer genomes. Am J Hum Genet. 2017, 100, 5-20.   [HTML][PDF]

14. Lu S, Jang H, Muratcioglu S, Gursoy A, Keskin O, Nussinov R*, Zhang J*. Ras conformational ensembles, allostery and signaling. Chem Rev. 2016, 116, 6607 - 6665.   [HTML][PDF]
(This paper is highlighted with the cover )

15. Zhao Y, Zhang X, Chen Y, Lu S, Peng Y, Wang X, Guo C, Zhou A, Zhang J, Luo Y, Shen Q, Ding J, Meng L*, Zhang J*. Crystal Structures of PI3Kα Complexed with PI103 and Its Derivatives: New Directions for Inhibitors Design. ACS Med Chem Lett. 2014, 5, 138 - 142.   [HTML][PDF]
(This paper was recommended by Faculty 1000 and ACS )

16. Huang Z, Zhu L, Cao Y, Wu G, Liu X, Chen Y, Wang Q, Shi T, Zhao Y, Wang Y, Li W, Li Y, Chen H*, Chen G, Zhang J*. ASD: a comprehensive database of allosteric proteins and modulators. Nucleic Acids Res. 2011, 39, D663 - 669.   [HTML][PDF]